SEC Form 4 · accession 0001246360-17-001436
NxStage Medical, Inc. · NXTM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Winifred L Swan
Officer — SVP and General Counsel
Period of report
Mar 20, 2017
Accepted (ET)
Mar 22, 2017 · 6:07 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001333170
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 20, 2017 | M | 15,223 | $18.59 | A | 30,993 | D | |
| Common Stock | Mar 20, 2017 | S | 15,723 | $27.66 | D | 15,270 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $18.59 | Mar 20, 2017 | M | 15,223 | D | Jun 27, 2011 | May 26, 2018 | Common Stock | 15,223 | 0 | D |
Explanation of responses
- F1This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2016.